Emory University’s Office of Technology Transfer (OTT) has selected EMRGE, LLC, (Now BRIJ Medical) founded by Felmont F. Eaves, III, MD to receive the 2018 Start-up of the Year Award at its annual celebration of Emory’s faculty entrepreneurs and their groundbreaking projects. Dr. Eaves will be presented with the award at OTT’s 12th Annual Celebration of Technology and Innovation, Thursday, March 15, 2018, at the Emory Conference Center. Registration for the event begins at 4:30 p.m., and the program starts at 5:00 p.m., followed by a reception. RSVP here (https://goo.gl/zJ34kM).
EMRGE, LLC, was founded by Dr. Eaves as a medical device company developing simple, cost-effective solutions for wound care, wound closure, and scar treatment. The company’s three-part platform consists of force-modulating tissue bridges, variable resistance backings, and bidirectional linear fixators. Together, these technologies offer a few key needs in wound care: approaches that don’t require anesthesia, don’t need active removal, minimize risk of infection, and reduce scarring. Dr. Eaves plans for EMRGE to begin marketing products by the end of 2018.
Dr. Eaves is the medical director of the Emory Aesthetic Center. He is considered a national expert in the development of new medical devices for endoscopic procedures, wound closure, and wound treatment. He is a previous president of the American Society for Aesthetic Plastic Surgery and serves as director of the American Board of Plastic Surgery. He has received numerous awards and honors, including being recognized as one of the Best Doctors in America continuously for more than a decade.
Emory’s OTT has more than 30 years of success in guiding scientific discoveries from the laboratory into the marketplace. Emory currently manages more than 1,500 technologies disclosed by its scientists and physicians. This has led to the formation of 82 new companies and the introduction of more than 46 new products into the marketplace, some of which, like the discovery of several HIV drugs, have had major health and societal impact.
